<--- Back to Details
First PageDocument Content
Myeloid leukemia / Genes / Piperazines / Chronic myelogenous leukemia / Philadelphia chromosome / Myeloproliferative disease / Abl gene / Acute myeloid leukemia / Imatinib / Oncology / Biology / Medicine
Myeloid leukemia
Genes
Piperazines
Chronic myelogenous leukemia
Philadelphia chromosome
Myeloproliferative disease
Abl gene
Acute myeloid leukemia
Imatinib
Oncology
Biology
Medicine

Journal Club Journal Club

Add to Reading List

Source URL: www.landesbioscience.com

Download Document from Source Website

File Size: 339,26 KB

Share Document on Facebook

Similar Documents

Hematology / Clinical medicine / Medicine / Acute myeloid leukemia / Myeloproliferative neoplasm / Leukemia / Pathology / Myelodysplastic syndrome / Acute leukemia / Essential thrombocytosis / Hematologic disease

1 Dr James Vardiman Professor Emeritus Department of Pathology University of Chicago

DocID: 1o8ES - View Document

Hematopathology / Acute leukemia / Acute myeloid leukemia / Myeloproliferative disease / Myelodysplastic syndrome / Polycythemia vera / Hematologic disease / Leukemia / Polycythemia / Medicine / Oncology / Myeloid leukemia

Molecular Diagnosis of Myeloid Neoplasias and Solid Tumors First report of mutations detected in the gene for NF-E2 Technology Myeloproliferative Neoplasms (MPN) are a group of several distinct, but clinically related ma

DocID: 1adts - View Document

Myelofibrosis / Essential thrombocytosis / Myeloproliferative disease / Plateletpheresis / Ruxolitinib / Megakaryocyte / Platelet / Bone marrow / Anemia / Medicine / Biology / Anatomy

Phase 2 trial of PRM-151, an anti-fibrotic agent, in patients with myelofibrosis: Stage 1 results Srdan Verstovsek1, Ruben Mesa2, Lynda Foltz3, Vikas Gupta4, John Mascarenhas5, Ellen Ritchie6, Ronald Hoffman5, Richard

DocID: 19YPO - View Document

Myelofibrosis / Janus kinase inhibitor / Essential thrombocytosis / Thrombocytosis / Splenomegaly / Polycythemia vera / Myeloproliferative disease / Thrombocytopenia / TG101348 / Medicine / Hematopathology / Ruxolitinib

Novartis Pharmaceuticals Canada Inc. 385 Bouchard Blvd. Dorval, Quebec Canada H9S 1A9 www.novartis.ca

DocID: 19fx5 - View Document

Polycythemia vera / Essential thrombocytosis / Fibrosis / Medicine / Myeloproliferative disease / Myelofibrosis

Phase 2 Trial of PRM-151, an Anti-Fibrotic Agent, in Patients with Myelofibrosis: Stage 1 Results S. Verstovsek1, R. Mesa2, L. Foltz3, V. Gupta4, J. Mascarenhas5, E. Ritchie6, R. Hoffman5, R. Silver6, W. J. Hong8, M. Kre

DocID: 19eKj - View Document